SCHEDULE 13G/A

ArriVent Biopharma Inc

Common Stock, $0.0001 Par Value per Share · CUSIP: 04272N102

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Suvretta Capital Management, LLC

  Shares: 3,412,788.00 · Class: 9.9%

• Averill Master Fund, Ltd.

  Shares: 2,969,098.00 · Class: 8.7%

• Aaron Cowen

  Shares: 3,412,788.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.